China’s NMPA Seeks Feedback on Drug Quality Management Provisions
China’s National Medical Products Administration (NMPA) has released a draft proposal titled “Provisions on the...
Policy / Regulatory
China’s NMPA Shifts to Electronic Drug Filings from January 2023
China’s National Medical Products Administration (NMPA) has released a notification indicating the initiation of electronic...
China’s Drug-Eluting Stent Procurement Results Announced
The national high-value medical consumables alliance procurement office has released the results of the successive...
NMPA Launches Electronic Certificates for API and Pharmaceutical Product Exports
The National Medical Products Administration (NMPA) has released a notification regarding the initiation of two...
China’s Medical Product Trade Surplus Declines Amid COVID-19 Impact
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Tianjin Tianyao Fined for Anti-Monopoly Violations in Carmustine Sales
China-based Tianjin Tianyao Pharmaceutical Co., Ltd (SHA: 600488) has been fined RMB 27.72 million (USD...
China Releases Third Batch of VAT Discounts for Anti-Tumor and Rare Disease Drugs
The Ministry of Finance, General Administration of Customs, State Taxation Administration, and National Medical Products...
Shanghai Hosts Yangtze River Delta Alliance VBP Tender for 44 Drugs
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has released a document indicating that the city will...
Shanghai Unveils Policies to Boost Global Biomedical R&D Hub
The Shanghai municipal government has released a set of policies and measures aimed at accelerating...
China’s CDE, HNMPA, and Bo’ao Lecheng Release Real-world Drug Research Measures
The Center for Drug Evaluation (CDE), Hainan Medical Products Administration (HNMPA), and Bo’Ao Lecheng Medical...
Jiangxi Healthcare Security Administration Launches New VBP Tender
The Jiangxi Healthcare Security Administration (JHSA) has released a notice of a new volume-based procurement...
Jiangxi Leads 22-Province Alliance in VBP for Liver Function Test Reagents
The provincial drug and medical consumables centralized procurement joint meeting office of Jiangxi has released...
CDE Issues Trial Rules for NMPA Drug Review Timekeeping Suspension
The Center for Drug Evaluation (CDE) has released the “NMPA Drug Review Timekeeping Suspension and...
CDE Issues Guidelines for Bispecific Antibody Antitumor Drug Development
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Clinical Research and...
China Updates Hypertension Guidelines, Lowers Diagnostic Threshold
The National Center for Cardiovascular Diseases, the Chinese Medical Doctor Association (CMDA), and other organizations...
China Releases 14th Five-Year Plan for National Health Informatization
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and the National Bureau...
CDE Seeks Public Feedback on New Drug Benefit-Risk Assessment Guidelines
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
CDE Releases Draft Guidelines on New Drug Benefit-Risk Assessment
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
CDE Releases Guidelines on Pediatric Anti-tumor Drug Development
The Center for Drug Evaluation (CDE) has released a Technical Guidelines document focused on “Clinical...
Hainan Free Trade Port to Simplify Drug Import Procedures
The “Provisions on Facilitation of Drug Import in Hainan Free Trade Port,” released in September...